Inspection Record

Jubilant Generics Limited — Health Canada Inspection Findings

Health CanadaInspected 2022-06-06 7 findingsEquipment and facilityQuality unit oversightOther quality systemComputer system validation

View the regulator's official source The source document is always the basis for judgement.

Findings

1Equipment and facility

The equipment was not set-up, designed, operated, stored, and/or maintained to prevent potential contamination of drugs by other drugs and/or by foreign material. The preventative maintenance and repair of the equipment was inadequate.

2Quality unit oversight

The annual product quality review procedure was inadequate.

3Other quality system

The evidence required to demonstrate compliance with finished product specifications was inadequate.

4Other quality system

The master production documents were inadequate.

5Computer system validation

The calibration, inspection, and/or qualification of the equipment, including computerized systems, was inadequate. The design, equipment, and/or maintenance of the testing laboratory was inadequate.

6Other quality system

The implementation and/or the effectiveness of the sanitation program in preventing unsanitary conditions was inadequate.

7Equipment and facility

The establishment and/or the maintenance of a data governance plan was inadequate.

About this record

Extracted automatically from the document of the Health Canada inspection on 2022-06-06. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Other records for this company

Jubilant Generics Limited company profile — full history Health Canada documents, 2022 Go to Findings search